Close

Athersys (ATHX) Receives FDA Okay Under a SPA for Phase 3 Study of MultiStem

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Athersys (ATHX) Receives FDA Okay Under a SPA for Phase 3 Study of MultiStem